Article
MAPT Haplotype Variation and Alzheimer's Disease Risk: A Narrative Review with Focus on the Jordanian Population.
Current neuropharmacology - 1 Jan 2026
Aljabali Alaa A A, Alkaraki Almuthanna K, Obeid Mohammad A
Abstract excerpt
INTRODUCTION: Genetic variations in the microtubule-associated protein tau (MAPT) gene play a central role in Alzheimer's disease (AD) pathogenesis. Two major MAPT haplotypes, H1 and H2, show differential associations with tau expression and AD risk. However, data from Middle Eastern populations remain limited, restricting our understanding of population-specific disease susceptibility patterns and therapeutic...
Topics
Join the communities discussing this publication.
